Feng Chi Biotech Corp. engages in the wholesale and retail of medical devices and precision instruments and biotechnology services in Taiwan and internationally. The company provides preimplantation genetic testing, prenatal testing, precision medicine, newborn screening, food/pharmaceutical microbiological testing, and medical translational research services, as well as infectious disease detection services. It also distributes various genetic and medical testing services. The company was founded in 1992 and is based in Taipei, Taiwan.
Frequently asked questions
What sector does Feng Chi Biotech Corp. (6744) operate in?
Feng Chi Biotech Corp. belongs to the Other sector and operates in the Biotechnology industry.
What is Feng Chi Biotech Corp. (6744) current stock price?
As of the latest data, Feng Chi Biotech Corp. stock price is NT$14.70, with a previous close of NT$14.70.
What is Feng Chi Biotech Corp. (6744) current market capitalization?
Feng Chi Biotech Corp. market cap is approximately 226.38 million.
What is Feng Chi Biotech Corp. (6744) Earnings Per Share (EPS)?
The trailing EPS is NT$0.94.
What is Feng Chi Biotech Corp. (6744) Price-to-Earnings (P/E) ratio?
Feng Chi Biotech Corp. current P/E ratio is 15.64.
Does Feng Chi Biotech Corp. (6744) pay dividends?
Yes. Feng Chi Biotech Corp. pays annual dividends with an annualized yield of 5.71% and an estimated annual payout of NT$0.84 per share.
When is the next ex-dividend date for Feng Chi Biotech Corp. (6744)?
The next ex-dividend date is scheduled for July 21, 2027.
What is Feng Chi Biotech Corp. (6744) beta (volatility) score?
Feng Chi Biotech Corp. has a beta of 0.278, indicating lower volatility than the overall market.
